Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)

HKG:1167 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,175	1,148	1,299	1,538	1,627
Cash & Short-Term Investments	1,175	1,148	1,299	1,538	1,627
Cash Growth	2.33%	-11.62%	-15.54%	-5.52%	417.73%
Accounts Receivable	7.68	9.34	15.03	64.92	171.41
Other Receivables	0.85	3.46	25.03	32.68	15.74
Receivables	8.53	12.8	40.06	97.59	187.16
Inventory	3.89	6.2	-	-	-
Other Current Assets	1.66	1.57	-	4.55	0.78
Total Current Assets	1,189	1,168	1,339	1,640	1,815
Property, Plant & Equipment	151.49	219.6	205.23	41.77	34.13
Long-Term Investments	18.16	68.19	25.42	16.23	-
Other Intangible Assets	0.84	1.37	1.02	1.55	1.17
Long-Term Accounts Receivable	0.06	2.91	-	-	-
Other Long-Term Assets	-	-	4.23	22.56	16.7
Total Assets	1,359	1,460	1,575	1,722	1,867
Accounts Payable	117.96	81.19	96.55	51.05	28.28
Accrued Expenses	7.56	17.96	25.4	19.15	14.59
Short-Term Debt	-	73.62	-	-	-
Current Portion of Long-Term Debt	56.06	-	-	-	-
Current Portion of Leases	9.9	14.33	13.13	4.92	8.64
Current Income Taxes Payable	1.04	1.94	2.35	1.97	1.73
Other Current Liabilities	50.33	16.1	18.42	3.75	20.64
Total Current Liabilities	242.85	205.13	155.85	80.83	73.88
Long-Term Debt	16	-	-	-	-
Long-Term Leases	70.12	121.97	134.66	1.89	2.01
Long-Term Unearned Revenue	0.78	1.19	1.61	2.02	5.26
Other Long-Term Liabilities	106.24	58.82	-	-	-
Total Liabilities	435.99	387.11	292.12	84.75	81.15
Common Stock	0.52	0.52	0.51	0.51	0.5
Retained Earnings	-3,350	-3,194	-2,835	-2,463	-2,162
Treasury Stock	-4.57	-	-	-	-
Comprehensive Income & Other	4,277	4,267	4,117	4,099	3,947
Total Common Equity	923.18	1,073	1,283	1,637	1,786
Shareholders' Equity	923.18	1,073	1,283	1,637	1,786
Total Liabilities & Equity	1,359	1,460	1,575	1,722	1,867
Total Debt	152.08	209.91	147.79	6.81	10.65
Net Cash (Debt)	1,022	937.93	1,151	1,531	1,617
Net Cash Growth	9.01%	-18.50%	-24.82%	-5.32%	474.68%
Net Cash Per Share	1.32	1.21	1.53	2.05	4.24
Filing Date Shares Outstanding	788.82	791.76	771.46	771.46	759.65
Total Common Shares Outstanding	788.82	791.76	771.46	771.46	759.65
Working Capital	945.77	963.28	1,183	1,559	1,741
Book Value Per Share	1.17	1.36	1.66	2.12	2.35
Tangible Book Value	922.34	1,072	1,282	1,636	1,785
Tangible Book Value Per Share	1.17	1.35	1.66	2.12	2.35
Machinery	57.83	59.38	53.3	50.03	42.14
Construction In Progress	-	-	27.79	-	-
Leasehold Improvements	62.1	61.86	10.2	10.2	8.02

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.